Leonteq AG (XSWX:LEON) Total Stockholders Equity : CHF780.1 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Leonteq AG Total Stockholders Equity?

Leonteq AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF780.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Leonteq AG's Book Value per Share for the quarter that ended in Dec. 2023 was CHF44.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Leonteq AG's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.05.

Leonteq AG Total Stockholders Equity Historical Data

The historical data trend for Leonteq AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Leonteq AG Total Stockholders Equity Chart

Leonteq AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

662.51

647.51

802.09

870.04

780.13

Leonteq AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															802.09	823.15	870.04	821.32	780.13

Leonteq AG (XSWX:LEON) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Leonteq AG's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(780.133	-	0)	/	17.5558
	=	44.44

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Leonteq AG's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.176	+	36.897)	/	780.133
	=	0.05

Leonteq AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Leonteq AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Leonteq AG (XSWX:LEON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Leonteq AG (XSWX:LEON) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LEONz:UK LEONE:Switzerland

Address

Europaallee 39, Zurich, CHE, 8004

Website

https://www.leonteq.com

Leonteq AG is a Swiss fintech company with a marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has a presence in its home market of Switzerland and Europe, as well as an established footprint in Asia.

Leonteq AG (XSWX:LEON) Headlines

From GuruFocus

Leone Asset Management's Subsidiary JP Anderson Signs MOU

By ACCESSWIRE • 09-20-2023

Leone Asset Management Signs Joint Venture

By ACCESSWIRE ACCESSWIRE • 04-20-2023

Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired • 03-29-2018

Leone Asset Management Signs Letter of Intent to Acquire New Energy Solutions

By ACCESSWIRE ACCESSWIRE • 07-18-2022

Leone Asset Management Releases Q1 Update

By ACCESSWIRE ACCESSWIRE • 04-11-2023

UPDATE: Go Epic Health to Begin Clinical Studies for Prostade

By Marketwired Marketwired • 03-29-2018